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INTRODUCTION
Malignant fibrous histiocytoma (MFH) is a rare primary
neoplasm occurring in the bone; according to Mayo Clinic files,
it accounts for less than 1% of primary bone tumors (1, 2).
The neoplasm is found most frequently in the long tubular
bones of the lower extremities (1). Only rare cases arising in
the skull have been published (3-6), and the majority of the
patients had large lytic areas of bone destruction with exten-
sions to the adjacent soft tissue, underlying dura, or brain pa-
renchyma. We experienced a rare case of primary MFH involv-
ing only a cranial vault with no extraosseous extensions in a
43-yr-old woman. This is an unusual presentation of MFH.
CASE REPORT
A 43-yr-old woman was admitted because of a palpable
mass in the right parietal region, which had enlarged in size
over the preceding 15 months. A physical examination revealed
tender swelling in the right parietal region. She had a histo-
ry of trauma in the same site 15 yr ago and no history of
irradiation. There was no evidence of soft tissue mass or con-
current illness. A plain skull radiograph showed a well-defined
lytic defect, measuring 5 cm in diameter in the right parietal
area (Fig. 1A). Computerized tomographic (CT) scanning de-
monstrated an area of extensive lytic bony destruction with
little discernible residual cortex and no significant periosteal
reaction. The margins were well delineated, and there was no
matrix formation within the lesion (Fig. 1B). T1-weighted
magnetic resonance (MR) images showed a pancake-shaped,
slightly low signal intensity mass with central nodularity, which
exhibited heterogeneous and slightly high signal intensity on
T2-weighted images and was well enhanced on contrast-en-
hanced MR images. No evidence of extensions to the adjacent
soft tissue and underlying dura mater was noted (Fig. 1C-F).
We suspected a benign osseous lesion, such as intraosseous
meningioma or eosinophilic granuloma, because of the less
aggressive radiological features, and a wide excision of the pari-
etal bone was performed. On operative findings, the tumor was
well distinguished from the nontumorous bone and was easily
detached from the underlying dura or the adjacent muscle.
The resected specimen was a solid, disk-shaped lesion yel-
lowish-brown in color and measuring 5×4×1 cm. It showed
a more nodular round area, corresponding to the nodular signal
pattern in the MR images. Histologically, the tumor consisted
of atypical spindle cells arranged in a storiform or fascicular pat-
tern (Fig. 2). The tumor cells showed high degree of pleomor-
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Primary Intraosseous Malignant Fibrous Histiocytoma of the Skull
: A Case Report
Malignant fibrous histiocytoma (MFH) is a rare primary neoplasm that constitutes
less than 1% of the malignant tumors of bone, and involvement of the skull is very
rare. We present a case of malignant fibrous histiocytoma of the skull, presenting
an intraosseous lesion in a 43-yr-old woman. She had a rapidly growing, tender
mass in the right parietal region. A plain radiograph showed an osteolytic lesion
of the right parietal bone. Magnetic resonance imaging revealed that the lesion
showed heterogeneous low signal intensity on T1-weighted images and slightly
high signal intensity on T2-weighted images. No evidence of an extraosseous exten-
sion to the adjacent dura and soft tissue was found, and a wide excision of the pari-
etal bone was performed. Histologically, the tumor was a typical MFH displaying
pleomorphic spindle cells in a storiform pattern. The results of immunohistochem-
ical stainings revealed that the tumor cells were positive for vimentin, -1-antitryp-
sin, and p53, and negative for smooth muscle actin, S100 protein, desmin, and
MyoD1. Three months later, a mainly cystic, recurrent mass was developed at the
previously operated site. Before the resection, we first performed the percutaneous
aspiration cytology, revealing diagnostic multinucleated pleomorphic cells. There-
after, she had to receive repetitive resections of recurrent or residual lesions, and
she died of postoperative meningoencephalitis two years after the first operation.
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phism with abundant eosinophilic cytoplasm and occasional
multinucleation, and abundant typical or atypical mitotic fig-
ures (Fig. 3). To exclude the possibility of MFH-like osteosar-
coma, we thoroughly searched for a tumor osteoid, but failed
to find it. Immunohistochemical staining revealed positive
reactivity for vimentin,  -1-antitrypsin, and p53. There was
no immunoreactivity for smooth muscle actin, S100 protein,
desmin, MyoD1, and cytokeratin.
Postoperatively, the patient underwent radiotherapy of 6120
cGy. Three months later, a progressive swelling was palpable
in the previously operated site. Follow-up MR images done at
that time demonstrated a subcutaneous fluid collection with
peripheral enhancement. A percutaneous needle aspiration was
subsequently performed. The cytologic findings of the aspira-
tion fluid obtained from the recurrent cystic lesion revealed
some scattered pleomorphic large cells in the background of
abundant inflammatory cells. These atypical cells frequently
showed binucleated or multinucleated forms with abundant
Fig. 1. (A-D) Radiologic findings. (A) Plain skull lateral film shows a round lytic defect, measuring 5 cm in diameter in the right parietal bone.
(B) Precontrast CT with bone setting shows a well-defined mass; the bony destruction is evident with little discernible residual inner and
outer table and periosteal reaction is meager. (C-F) The tumor is confined to cranial vault showing slightly low signal intensity on T1-weight-
ed axial MR image (C) and slightly heterogeneous signal intensity on T2-weighted axial image (D) comparing to the brain, and the tumor is
enhanced well on contrast-enhanced T1-weighted axial (Fig. 1. continued next)
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cytoplasm (Fig. 4). Thereafter, the patient received another
operation, and the lesion was histologically confirmed to be
the recurrent tumor.
DISCUSSION
Although many cases of MFH in soft tissues have been re-
ported, the descriptions of their occurrences in bony areas are
rare (1, 2, 7-9), and extremely rare in the skull. The mandibu-
lomaxillary area was the most common site for MFH in the
skull (3-4), followed by the calvarium. We found eight cases
of MFH in the calvarium (5-6): in the frontal bone and tempo-
ral bone (two patients each); and in the frontotemporal bone,
occipital bone, parietal bone, and clivus (one patient each). The
patients’ ages ranged from 25 to 72 yrs old. There were five
males and three females. Most of them had rapidly enlarging
painless masses on the skull, as in the present case.
Fig. 2. Pleomorphic spindle cells are arranged in a storiform pat-
tern (H&E, ×100).
Fig. 3. Tumor cells show high degree of pleomorphism with frequent
multinucleation and mitotic figures (H&E, ×400).
Fig. 1. (Continued form the previous page) (E) and coronal (F) MR images. The involvement of adjacent scalp, dura, or brain parenchyme
is not apparent.
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In addition to its unusual location, the radiologic findings
of the present case were unique. At initial presentation, the
lesion was confined to the cranial bone with no definite evi-
dence of extraosseous (adjacent soft tissue, dura mater, or brain
parenchyma) extensions. Typical radiologic findings of MFH
include purely osteolytic, aggressive, destructive tumor growth
with frequent soft tissue involvement, and periosteal reactions
and expansile growth were rarely seen (10, 11). In all reported
cases arising in the skull, the tumors involved all layers with
inward and/or outward extensions and were sometimes pre-
sented as an intracranial or a soft tissue mass (5, 6). In our case,
some favorable findings to benign lesions were apparent; the
tumor size was not small, but placed horizontally along the
cranial vault, and it displayed good localization with no defi-
nite extraosseous extensions. Considering the case retrospec-
tively, extensive osteolysis with cortical destruction as well as
an inhomogeneous nodular signal pattern on T2-weighted and
contrast-enhanced T1-weighted MR images were suggestive
of a malignant osseous lesion.
Before making a diagnosis of MFH, the exclusion of other
types of pleomorphic sarcoma with dedifferentiated areas is
mandatory because their histologic appearance is akin to MFH
(1, 2, 12, 13). The marked pleomorphism with multinucleated
giant cells and a storiform pattern observed in the present case
were consistent with the characteristic histological findings of
MFH. Moreover, differentiation to specific cells, such as
smooth muscle cells, skeletal muscle cells, or fat cells, was not
detected immunohistochemically, and there was no tumor
osteoid suggestive of bone-forming tumor throughout the
lesion. Naka et al. (13) reported that no overexpressions of the
p53 protein were found in the MFH-like osteosarcoma, where-
as it tended to occur more frequently in MFH of the bone. In
our case, a significant overexpression of the p53 protein was
demonstrated.
At the first time of recurrence, the lesion was predominantly
cystic with only peripheral enhancement. We thought that
this lesion had to be discriminated from the retained hema-
toma, and then we first performed the percutaneous aspiration
cytology, which revealed diagnostic tumor cells. Multinucle-
ated bizarre nuclei and abundant cytoplasm are thought to be
characteristic cytologic findings for identifying the histiocytic
features of this tumor. Although the final diagnosis of the re-
current tumor relied on the histologic findings, the cytologic
examination was helpful as an auxiliary study in our case.
All reported patients underwent gross total removal of the
tumor; nevertheless, the prognosis is poor, similar to MFHs
occurring in the other sites of the body (1, 2, 8, 12, 14). Our
patient received wide resection of the affected skull bone with
the adjacent dura and soft tissue followed by irradiation, and
we expected a hopeful outcome considering the less aggressive
presentation of the tumor. However, the patient had to receive
repetitive resections of recurrent or residual lesions, and she
died of postoperative meningoencephalitis two years after the
first operation. We believe that adjuvant chemotherapy would
have been necessary for this patient, as previous report stressed
the usefulness of chemotherapy (14).
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